National Health Investors (NHI) Upgraded to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of National Health Investors (NYSE:NHI) from a sell rating to a hold rating in a research report report published on Tuesday.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

A number of other equities research analysts have also recently commented on NHI. ValuEngine raised National Health Investors from a hold rating to a buy rating in a report on Tuesday, December 11th. KeyCorp set a $65.00 price objective on National Health Investors and gave the company a sell rating in a research report on Thursday, December 20th. Finally, Cantor Fitzgerald restated a hold rating and set a $80.00 price objective on shares of National Health Investors in a research report on Thursday, November 8th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of Hold and a consensus target price of $75.38.

Shares of National Health Investors stock opened at $82.08 on Tuesday. National Health Investors has a one year low of $63.00 and a one year high of $84.23. The firm has a market capitalization of $3.52 billion, a P/E ratio of 15.40 and a beta of 0.51. The company has a current ratio of 14.53, a quick ratio of 14.53 and a debt-to-equity ratio of 0.89.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 31st. Stockholders of record on Monday, December 31st were given a dividend of $1.00 per share. The ex-dividend date of this dividend was Friday, December 28th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 4.87%. National Health Investors’s payout ratio is 75.05%.

In other news, CIO Kevin Carlton Pascoe sold 2,070 shares of the firm’s stock in a transaction dated Friday, December 14th. The stock was sold at an average price of $79.60, for a total transaction of $164,772.00. Following the completion of the transaction, the executive now owns 25,123 shares in the company, valued at $1,999,790.80. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Kristin Sallee Gaines sold 10,708 shares of the firm’s stock in a transaction dated Thursday, December 13th. The shares were sold at an average price of $80.36, for a total value of $860,494.88. Following the transaction, the insider now owns 43,644 shares of the company’s stock, valued at approximately $3,507,231.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 14,028 shares of company stock valued at $1,119,529. Company insiders own 5.63% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in National Health Investors by 1.2% in the third quarter. Vanguard Group Inc. now owns 6,382,904 shares of the real estate investment trust’s stock worth $482,484,000 after acquiring an additional 76,209 shares in the last quarter. Vanguard Group Inc grew its position in National Health Investors by 1.2% in the third quarter. Vanguard Group Inc now owns 6,382,904 shares of the real estate investment trust’s stock worth $482,484,000 after acquiring an additional 76,209 shares in the last quarter. BlackRock Inc. grew its position in National Health Investors by 1.7% in the fourth quarter. BlackRock Inc. now owns 4,216,426 shares of the real estate investment trust’s stock worth $318,508,000 after acquiring an additional 71,399 shares in the last quarter. Dimensional Fund Advisors LP grew its position in National Health Investors by 1.0% in the third quarter. Dimensional Fund Advisors LP now owns 645,077 shares of the real estate investment trust’s stock worth $48,759,000 after acquiring an additional 6,456 shares in the last quarter. Finally, Renaissance Technologies LLC grew its position in National Health Investors by 32.5% in the third quarter. Renaissance Technologies LLC now owns 636,240 shares of the real estate investment trust’s stock worth $48,093,000 after acquiring an additional 155,940 shares in the last quarter. Institutional investors own 69.65% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also: Depreciation

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit